Changes in behavior and biomarkers during the diagnostic decision period for COVID-19, influenza, and group A streptococcus (GAS): a two-year prospective cohort study in Israel
Changes in behavior and biomarkers during the diagnostic decision period for COVID-19, influenza, and group A streptococcus (GAS): a two-year prospective cohort study in Israel
Shachar Snir, Tel-Aviv University Advisor: :Prof. Dan Yamin(TAU)
Abstract:
Limited knowledge exists regarding behavioral and biomarker shifts during the period from respiratory infection exposure to testing decisions (the diagnostic decision period), a key phase affecting transmission dynamics and public health strategy development. This study aims to examine the changes in behavior and biomarkers during the diagnostic decision period for COVID-19, influenza, and group A streptococcus (GAS). We analyzed data from a two-year prospective cohort study involving 4795 participants in Israel, incorporating smartwatch data, self-reported symptoms, and medical records. Our analysis focused on three critical phases: the digital incubation period (from exposure to physiological anomalies detected by smartwatches), the symptomatic incubation period (from exposure to onset of symptoms), and the diagnostic decision period for influenza, COVID-19, and GAS.
Bio:
Shachar Snir, M.Sc. student at the department of Industrial Engineering in Tel Aviv University, specializing in Data Science. Shachar holds a B.SC. Degree in Industrial Engineering from Tel Aviv University. Her research, supervised by Prof. Dan Yamin, focuses on analyzing data from a 5,000-participant clinical trial using smartwatches for early disease detection and clinical trials improvements.
